Supplement Formula Intellectual Property: Who Owns the Formula in OEM & ODM Cooperation
Many overseas nutritional supplement brands overlook a critical issue when collaborating with OEM or ODM manufacturers: who actually owns the formula? Numerous new brands mistakenly believe that once they pay for prototyping and production fees, the product formula becomes entirely their own. Others confuse concepts such as copyright, patents, and trade secrets, only to discover—after their product becomes popular—that the same formula has been sold to competing brands, or that they cannot obtain complete formula documentation when switching manufacturers, leaving them at a disadvantage. In the dietary supplement industry, formulas represent one of a brand’s most valuable intangible assets. Clarifying intellectual property boundaries and securing ownership early in partnerships is essential for long-term, stable growth.
First, it's important to correct a common misconception: formulas themselves are not protected by "copyright." Copyright protects the expression of content such as text, images, copywriting, and label designs—it safeguards "how something is written," not the technical solution embodied in the formula itself. 。 In other words, the packaging copy, promotional graphics, and instruction manuals for your product fall under copyright protection. However, raw material formulations, production processes, and blending schemes are not protected as copyrightable subject matter. What many people refer to as "formula copyright" is essentially a colloquial term encompassing intellectual property rights, trade secrets, or patents related to formulas—this is common industry jargon. But when drafting contracts or confidentiality agreements, it's crucial to distinguish clearly among these concepts to avoid legal loopholes.
The ownership of formulas varies dramatically depending on the manufacturing model, which is also where brands most commonly run into pitfalls. The first model involves using existing private-label standard formulas from the factory’s in-house formula library—brands simply select a product, change the packaging, and rebrand it. In this case, the intellectual property rights of the formula belong to the factory; the brand only acquires sales rights. The factory may sell the same formula to multiple brands unless an exclusive licensing agreement is separately signed. This model offers advantages such as low minimum order quantities, fast time-to-market, and controllable costs, making it ideal for new brands testing products quickly. However, the downside is that the formula isn't exclusive, making it easy to encounter market saturation with similar products and lacking differentiation or competitive barriers.
The second model is OEM (Original Equipment Manufacturing), where the brand provides its own complete formula, ingredient specifications, and process documentation for the factory to produce. In this scenario, the formula belongs to the brand from the outset. The factory merely manufactures according to the client’s technical documents and has a duty to strictly maintain confidentiality, prohibiting unauthorized disclosure or resale of the formula to third parties. The brand retains full control over all formula-related materials and can switch manufacturers at any time, ensuring complete ownership of the formula assets.
The third model is ODM (Original Design Manufacturing) custom development, where the brand outlines requirements and the factory’s R&D team develops the formula from scratch, fine-tunes it, and conducts stability testing. This area is particularly prone to disputes: the default assumption—that “once you pay for development, the formula automatically belongs to the brand”—is incorrect. Ownership depends entirely on the contract terms. If the agreement does not explicitly state a transfer of intellectual property rights, even after paying for R&D, the formula remains the factory’s property. Only after the contract clearly stipulates formula transfer and completes the necessary transfer procedures will the brand gain full ownership, receiving the entire set of formulas, processes, and test data, and then freely choosing its preferred manufacturer. 。 Many startups fall into this trap: after developing a hit product, the factory refuses to hand over the formula, leaving the brand locked into a long-term relationship with that single manufacturer and stripped of pricing power.
Beyond ownership, two other critical concepts must be clarified upfront by brands: exclusivity and confidentiality obligations. Exclusivity can take forms such as regional, channel-specific, or full-market exclusivity, and the agreement should clearly define the duration, scope, and whether it includes the factory’s own use. The NDA (Non-Disclosure Agreement) is not just a formality—it must explicitly state that formula documentation, test reports, process parameters, and sample information are all confidential. Factory employees, R&D teams, and supply chain partners must not disclose these details, and the confidentiality obligation remains in effect even after the partnership ends.
Throughout our extensive experience in OEM and ODM manufacturing for nutritional supplements, we have consistently clarified the boundaries around formula intellectual property. For OEM orders using client-provided formulas, we strictly enforce NDAs—formula ownership always remains with the brand, and we only fulfill production responsibilities without retaining or sharing the formula. For custom ODM development, we offer two collaboration models: either using one of our factory’s proven existing formulas for fast launch, or co-developing a proprietary formula. Once agreed terms are met, we fully transfer the formula’s intellectual property rights to the brand, while maintaining strict control through an NDA throughout the entire process to safeguard brand assets. Whether developing gummies, capsules, tablets, powders, or drops, IP clauses can be seamlessly integrated into cooperation agreements across all dosage forms.
The formula is a brand’s core asset. Many brands focus solely on sales performance, pricing, and minimum order quantities, overlooking the foundational protection offered by intellectual property. When products become popular, competitors copy the formula or factories sell it to others, making legal action costly, evidence difficult to obtain, and losses nearly impossible to recover. Clearly distinguishing between copyright, patents, and trade secrets, securing formula ownership early, and establishing strong confidentiality terms at the outset are essential to confidently build differentiated products and establish lasting competitive advantages in overseas markets. If you’re planning to develop a custom formula and want to understand the details of NDAs and formula transfer agreements, feel free to contact Formuvita.